Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02548559 · ClinicalTrials.gov registry record · Phase 2

Sublingual Cannabidiol for Anxiety

A Phase 2 study of Anxiety, sponsored by Staci Gruber, Ph.D..

Completed
Registry status
Phase 2
Development phase
31
Enrollment target
1
Study location

NCT02548559 is a Phase 2 study of Anxiety that has completed, run by Staci Gruber, Ph.D.. The registered enrollment target is 31 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02548559, a Phase 2 study of Anxiety, has completed, sponsored by Staci Gruber, Ph.D..

COMPLETED
Registry status
Phase 2
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

This is an open-label to double-blind study evaluating the effects of cannabidiol (CBD) for the treatment of anxiety in adults. Participants will use a sublingual (under-the-tongue) solution of whole plant-derived CBD or placebo three times daily for four weeks in addition to their normal treatment regimen. Participants' clinical state will be assessed weekly during the treatment period. In addition, cognitive function and measures of quality of life, sleep, and general health will be assessed at baseline and the post-treatment final visit.

Conditions Studied

Anxiety

Interventions

  • DRUG Placebo
  • DRUG Full-Spectrum Cannabidiol
  • DRUG Single-Compound Cannabidiol

Study Locations (1)

Massachusetts

  • McLean Hospital Brain Imaging Center - Belmont

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2018-08-14
Est. Completion 2025-03-13
Phase Phase 2

Sponsor

Staci Gruber, Ph.D.

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02548559

The ClinicalTrials.gov registry entry for NCT02548559 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (93% lower). The listed sponsor is Staci Gruber, Ph.D., which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT02548559 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT02548559 about?

NCT02548559 is a clinical study titled "Sublingual Cannabidiol for Anxiety". This is an open-label to double-blind study evaluating the effects of cannabidiol (CBD) for the treatment of anxiety in adults. Participants will use a sublingual (under-the-tongue) solution of whole plant-derived CBD or placebo three times daily for four weeks in addition to their normal treatment ...

What is the current status of trial NCT02548559?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 31 participants. The study started on 2018-08-14. Estimated completion is 2025-03-13.

What conditions does trial NCT02548559 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT02548559?

The interventions under investigation include: Placebo (DRUG), Full-Spectrum Cannabidiol (DRUG), Single-Compound Cannabidiol (DRUG).

Who is sponsoring clinical trial NCT02548559?

This trial is sponsored by Staci Gruber, Ph.D., which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02548559 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Anxiety

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.